--- title: "Assessing Herbalife (HLF) Valuation After A Sharp Multi‑Month Share Price Rebound" type: "News" locale: "en" url: "https://longbridge.com/en/news/276639934.md" description: "Herbalife (HLF) has seen a significant share price rebound, currently at $19.96, with a 20% return over the past month and 67% over three months. Despite a 56% decline over five years, the stock shows a 140% return in the last year. Analysts suggest it may be overvalued at $19.96, with a fair value estimate of $14, while a DCF model indicates a potential value of $30.97. Investors are encouraged to consider both perspectives and explore additional investment opportunities." datetime: "2026-02-23T20:11:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276639934.md) - [en](https://longbridge.com/en/news/276639934.md) - [zh-HK](https://longbridge.com/zh-HK/news/276639934.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276639934.md) | [繁體中文](https://longbridge.com/zh-HK/news/276639934.md) # Assessing Herbalife (HLF) Valuation After A Sharp Multi‑Month Share Price Rebound ## What recent performance says about Herbalife stock Herbalife (HLF) has drawn fresh attention after a strong run, with the share price at $19.96 and total return figures of 20% over the past month and 67% over the past 3 months. For longer term holders, the stock shows a 56% decline over 5 years, alongside a 140% total return over the past year and a modest 2% total return over 3 years. This highlights mixed holding period experiences. See our latest analysis for Herbalife. The recent surge in Herbalife’s share price, including a 25.53% 7 day share price return and 55.69% year to date share price return at a last close of $19.96, points to building momentum after a weak multi year total shareholder return. In the short term, the market appears more willing to price in potential upside or lower perceived risk, even as the 5 year total shareholder return of 55.62% decline keeps the longer term record muted. If Herbalife’s rebound has you looking beyond a single name, it could be a good moment to broaden your search with our screener of 22 top founder-led companies. So, with Herbalife trading at $19.96, a value score of 5, an intrinsic discount of 35.54%, and a price target of $16.50, is the rebound signaling an undervalued setup, or has the market already priced in future growth? ## Most Popular Narrative: 43% Overvalued Herbalife’s most followed narrative pegs fair value at $14 against a last close of $19.96, so the market price currently sits well above that estimate, even after accounting for a discount rate of 10.30% in the model. > _The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations._ Read the complete narrative. Want to see what is driving that higher margin outlook and upgraded fair value? The narrative focuses on future earnings power, steadier sales growth and a richer earnings multiple. Curious how those ingredients fit together and what assumptions sit underneath the discount rate and fair value change? **Result: Fair Value of $14 (OVERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, there is still a chance that stronger product momentum or progress in personalized wellness and technology platforms could support higher earnings power than this cautious view allows. Find out about the key risks to this Herbalife narrative. ## Another view on Herbalife’s valuation While the popular narrative sees Herbalife as 43% overvalued at $19.96 versus a $14 fair value, the SWS DCF model points in the other direction, with an estimated future cash flow value of $30.97, or about 35.5% above the current price. Which framework do you think better fits your own assumptions? Look into how the SWS DCF model arrives at its fair value. HLF Discounted Cash Flow as at Feb 2026 ## Next Steps After all this, are you feeling cautious or intrigued by Herbalife’s setup? Take a closer look at the full picture, weigh both sides, and move quickly to form your own stance with 3 key rewards and 2 important warning signs. ## Looking for more investment ideas? If Herbalife has sharpened your focus, do not stop here. Use this momentum to scan fresh ideas and keep your watchlist stocked with strong candidates. - Target resilient potential by running your filters through our 85 resilient stocks with low risk scores that prioritize balance sheet strength and historically steadier risk profiles. - Hunt for value opportunities with our 53 high quality undervalued stocks where solid fundamentals and conservative assumptions help you spot ideas that may be priced below their calculated worth. - Spot opportunities others might skip by checking the screener containing 23 high quality undiscovered gems focused on companies with quality metrics that have not yet attracted wider attention. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if Herbalife might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [First Trust Nasdaq Food & Beverage ETF (FTXG.US)](https://longbridge.com/en/quote/FTXG.US.md) - [The Consumer Staples Sel SectSPDR® ETF (XLP.US)](https://longbridge.com/en/quote/XLP.US.md) - [iShares US Consumer Staples ETF (IYK.US)](https://longbridge.com/en/quote/IYK.US.md) - [Herbalife Ltd. (HLF.US)](https://longbridge.com/en/quote/HLF.US.md) - [Invesco Food & Beverage ETF (PBJ.US)](https://longbridge.com/en/quote/PBJ.US.md) - [Vanguard Consumer Staples ETF (VDC.US)](https://longbridge.com/en/quote/VDC.US.md) ## Related News & Research - [Herbalife to Announce First Quarter 2026 Results on May 6 | HLF Stock News](https://longbridge.com/en/news/281353950.md) - [Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq | HLF Stock News](https://longbridge.com/en/news/280611053.md) - [Hershey Stock (HSY) Looks Sweeter After Company Promises Return to Classic Reese's](https://longbridge.com/en/news/281415413.md) - [West Branch Capital LLC Has $402,000 Stock Holdings in PepsiCo, Inc. $PEP](https://longbridge.com/en/news/281635112.md) - [Barfresh Food Q4 revenue soars, driven by Arps Dairy acquisition](https://longbridge.com/en/news/281240001.md)